285 related articles for article (PubMed ID: 11054156)
1. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
Montplaisir J; Denesle R; Petit D
Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
[TBL] [Abstract][Full Text] [Related]
2. Restless legs syndrome improved by pramipexole: a double-blind randomized trial.
Montplaisir J; Nicolas A; Denesle R; Gomez-Mancilla B
Neurology; 1999 Mar; 52(5):938-43. PubMed ID: 10102409
[TBL] [Abstract][Full Text] [Related]
3. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
[TBL] [Abstract][Full Text] [Related]
4. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
Stiasny-Kolster K; Oertel WH
Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
[TBL] [Abstract][Full Text] [Related]
5. Encouraging initial response of restless legs syndrome to pramipexole.
Becker PM; Ondo W; Sharon D
Neurology; 1998 Oct; 51(4):1221-3. PubMed ID: 9781569
[TBL] [Abstract][Full Text] [Related]
6. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
Winkelman JW; Johnston L
Sleep Med; 2004 Jan; 5(1):9-14. PubMed ID: 14725821
[TBL] [Abstract][Full Text] [Related]
7. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
8. Pramipexole for the treatment of restless legs syndrome.
Kushida CA
Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
[TBL] [Abstract][Full Text] [Related]
9. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
10. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
11. Effect of pramipexole in treatment of resistant restless legs syndrome.
Lin SC; Kaplan J; Burger CD; Fredrickson PA
Mayo Clin Proc; 1998 Jun; 73(6):497-500. PubMed ID: 9621854
[TBL] [Abstract][Full Text] [Related]
12. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole in the management of restless legs syndrome: an extended study.
Silber MH; Girish M; Izurieta R
Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with pramipexole in the treatment of restless legs syndrome.
Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
[TBL] [Abstract][Full Text] [Related]
15. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome and its treatment by dopamine agonists.
Stiasny K; Wetter TC; Trenkwalder C; Oertel WH
Parkinsonism Relat Disord; 2000 Nov; 7(1):21-25. PubMed ID: 11008192
[TBL] [Abstract][Full Text] [Related]
17. Dopamine agonists for restless legs syndrome.
Scholz H; Trenkwalder C; Kohnen R; Riemann D; Kriston L; Hornyak M
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD006009. PubMed ID: 21412893
[TBL] [Abstract][Full Text] [Related]
18. Switching from pergolide to pramipexole in patients with Parkinson's disease.
Hanna PA; Ratkos L; Ondo WG; Jankovic J
J Neural Transm (Vienna); 2001; 108(1):63-70. PubMed ID: 11261747
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole for Chinese people with primary restless legs syndrome: a 12-week multicenter, randomized, double-blind study.
Zhang J; Liu B; Zheng Y; Chu T; Yang Z
Sleep Med; 2015 Jan; 16(1):181-5. PubMed ID: 25533540
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]